Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of horse serum amyloid protein A1 and expression vector and genetic engineering bacteria thereof

An amyloid protein and genetically engineered bacteria technology, applied in genetic engineering, botanical equipment and methods, biochemical equipment and methods, etc., can solve the problems of unstable activity, less soluble protein, and low expression, and avoid changes. Effects of renaturation steps, preservation of biological activity, and simplified purification methods

Active Publication Date: 2014-02-26
DIASYS DIAGNOSTIC SYST SHANGHAI
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Secondly, for in vitro recombinant expression and purification of SAA1, due to its protein characteristics, such as easy aggregation in vitro and low expression level, there are shortcomings such as less soluble protein obtained from expression and complicated purification methods. These shortcomings have long restricted SAA1 in vitro. Further development of research
In addition, most of the recombinant SAA1 proteins obtained by the above two methods are inclusion bodies, and 6M urea or guanidine hydrochloride must be used in the purification process to take complex methods such as denaturation and renaturation of the purified target protein, so that the obtained recombinant protein is purified biologically. Low activity and unstable activity
In addition, this purification method takes a long time, has low yield, high cost, and is not conducive to mass production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of horse serum amyloid protein A1 and expression vector and genetic engineering bacteria thereof
  • Preparation method of horse serum amyloid protein A1 and expression vector and genetic engineering bacteria thereof
  • Preparation method of horse serum amyloid protein A1 and expression vector and genetic engineering bacteria thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 Cloning of the gene encoding hoSAA1 and construction of the recombinant expression plasmid pET28a(+)-hoSAA1

[0041] The steps of gene cloning and plasmid construction are as follows:

[0042] (1) The hoSAA1 gene, as shown in SEQ ID NO.1, was synthesized by Invitrogen and cloned into the pBluescriptII vector;

[0043] (2) Subcloning of the hoSAA1 gene;

[0044] ①Transform the obtained pBluescriptII-SAA1 vector into DH5a host bacteria, screen and extract the plasmid containing the target DNA fragment;

[0045] ②Then undergo double enzyme digestion and separate the target DNA fragment by agarose gel electrophoresis;

[0046] ③ After purifying the target DNA fragment with a gel recovery kit, it was directly ligated to the pET-28a(+) vector;

[0047] ④ Transform the ligated product into DH5a host bacteria, extract the plasmid, and identify it by double enzyme digestion with NdeI and HindIII. Among them, the size of the enzyme-digested fragment is consistent wi...

Embodiment 2

[0053] Large-scale expression and purification method of embodiment 2 gene recombinant bacteria

[0054] Expression of recombinant hoSAA1-polyhistidine fusion protein in Escherichia coli host

[0055] 1) Transform PET28a-hoSAA1 into Rosetta-gami Escherichia coli on an LB culture plate with kanamycin resistance (50ng / ml), culture at 37°C overnight;

[0056] 2) pick a single colony in 50ml LB medium containing 50μg / ml kanamycin, and culture overnight at 37°C and 250 rpm;

[0057] 3) 2% was inoculated into 1L LB medium (including 50ug / ml kanamycin), and the bacteria were cultivated to A600 at 37°C and 250 rpm, with an O.D value of 0.5;

[0058] 4) Add IPTG to a final concentration of 1 mM and induce culture at 37°C and 300 rpm for 3 hours;

[0059] 5) Centrifuge at 4000 rpm for 20 minutes at high speed, collect the precipitate and store it at -80°C.

[0060] Reagent for purifying recombinant hoSAA1-polyhistidine fusion protein

[0061] (1) Lysis solution: 50mM Tris-HCl pH 8.0...

Embodiment 3

[0076] Embodiment 3 Western blotting proves to recombinant protein

[0077] 1) 15% acrylamide glue, 90V, 3 hours;

[0078] 2) Electrotransfer the protein fragments on the acrylamide gel to PVDF membrane through Tris-glycine buffer solution, the conditions are 1X Tris-glycine buffer solution, 20% methanol, 70V voltage for 3 hours at room temperature;

[0079] 3) Take out the PVDF membrane after electrotransfer and wash it with 1X PBST for 30 minutes;

[0080] 4) block with PBST containing 5% skimmed milk powder for 45 minutes;

[0081] 5) Rinse the PVDF membrane with 1X PBST 3 times, 10 minutes / time;

[0082] 6) Add 8 mL of PBST containing 1:2000 diluted anti-His antibody, and react at room temperature for 1 hour;

[0083] 7) Wash the PVDF membrane three times with 1X PBST, 15 minutes / time;

[0084] 8) Add anti-mouse antibody containing 1:1000 dilution and react at room temperature for 40 minutes;

[0085] 9) Wash the PVDF membrane three times with 1X PBST, 15 minutes / time...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of soluble genetic engineering horse serum amyloid protein A1 (hoSAA1) and an expression vector and genetic engineering bacteria thereof. The expression vector provided by the invention is a plasmid vector pET28a (+) containing a gene sequence of the hoSAA1, and an hSAA1 coding sequence is arranged between restriction enzyme cutting sites of Nde I and HindIII on the pET28a (+) vector. The genetic engineering bacteria provided by the invention are Escherichia coli, which is pET28a (+)-hoSAA1 / Rosetta-gami and expressible and soluble target protein. The preparation method adopts a nickel cross-linking affinity column one-step method, the affinity column is washed twice by imidazole of different concentrations, and the method has simple and convenient operation, high yield and short consuming time and is suitable for industrialized large-scale production.

Description

technical field [0001] The present invention relates to the field of protein or polypeptide production by DNA recombination technology, more specifically, the present invention relates to the method for preparing horse serum amyloid A1 (serum amyloid A1, hoSAA1) through genetic engineering, and also relates to related expression vectors and engineering bacteria. Background technique [0002] Serum amyloid A1 (serum amyloid A, SAA1) is an acute phase response apolipoprotein, which is a group of pleomorphic proteins encoded by the same cluster of genes. Mainly synthesized by liver cells. The specific binding region of its N-terminal forms SAA1-HDL particles with high-density lipoprotein (HDL), and then regulates the metabolism of high-density lipoprotein to enhance the affinity with macrophages and transport lipids to inflammatory sites. SAA1 is an effective medium Granulocyte activator, enhances the antibacterial effect of neutrophils and inhibits fungal infection. In addit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/70C12N1/21C12N15/12C07K14/47C12R1/19
Inventor 吴峻王荣芳张艳钱震斌
Owner DIASYS DIAGNOSTIC SYST SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com